The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.50
Bid: 13.00
Ask: 15.00
Change: 0.00 (0.00%)
Spread: 2.00 (15.385%)
Open: 14.50
High: 14.50
Low: 14.50
Prev. Close: 14.00
CAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Board Changes

15 Jan 2018 07:00

RNS Number : 8072B
Carclo plc
15 January 2018
 

15 January 2018

 

 

Carclo plc

Trading Update and Board Changes

 

Carclo plc ("Carclo" or the "Group"), the global manufacturing group, announces a trading update for the year ending 31 March 2018.

Trading update

The stronger second half performance across the Group, anticipated at the time of the Interim Results in November last year, is not now expected to be achieved. Accordingly, the Board now expects the Group's performance for the current financial year to be significantly lower than previously planned.

While the previously reported operational issues at Technical Plastics have been addressed, there has been an unexpected delay in the awarding of two large tooling and automation contracts. In addition, a large and long standing non-medical customer which had been indicating a strong second half for our moulded components has not yet increased its orders. The impact of these factors is such that the division's profit for the current year is now expected to be significantly below expectations.

Within LED Technologies, the Group's LED super car lighting business has performed as anticipated and new product launches have continued to be made on time. However, while the Wipac business has continued to operate well, delays in the award of three new contracts are expected to materially reduce the division's profit for the current year. It is still anticipated that Wipac will be successful in winning a number of these programmes despite the uncertainty on timing.

The Board expects the Group's profits for the year ending 31st March 2018 to be significantly lower than its previous expectations. In addition, as a consequence of some of these delayed projects and lower customer orders, the Board has now reduced its profit expectations for the 2018/19 financial year albeit these revised expectations will still represent healthy year on year growth.

The Board recognises there is an ongoing reliance upon winning new tooling and automation contracts to drive profitability in Technical Plastics. However it is also cognisant that such reliance must be offset by higher and more sustainable underlying operating margins from existing business and therefore targeting improved margins has been an ongoing initiative. In view of the disappointing reduction in anticipated profitability for the current year, a more fundamental and urgent review of operating efficiencies and margins at this division is to be undertaken.

The Group's financing remains healthy and it continues to operate well within its banking covenants.

While this is a setback, the Board believes that the medium term outlook for the Group remains positive. The LED Technologies business is still expected to grow significantly, moving forwards as the previously awarded mid-volume programmes commence production from 2019, and the new medical programmes won in Technical Plastics are expected to underpin good growth in this division.

Board changes

The Board announces today that, after 14 years as Group Finance Director, Robert Brooksbank is leaving the Group on 31 March 2018 to pursue other career and business opportunities. The Board would like to thank Robert for his significant contribution to Carclo over this period and wish him well in the future. The Board is initiating the process to recruit a new finance director and in the meantime Richard Ottaway, Group Financial Controller and Company Secretary, will act as the Interim Chief Financial Officer from 1 April 2018 until a permanent successor is appointed.

In addition, the Board announces that Michael Derbyshire will retire from the Board at the Group's Annual General Meeting in July 2018 after nearly six years as Chairman and over 12 years as a Non-Executive Director. Michael has made a substantial contribution to the strategic direction of the Company and the Board thanks him and wishes him well for the future.

Mark Rollins, who joined the Board as Non-Executive Director on 1 January 2018, will become Chairman at the conclusion of the Annual General Meeting.

 

 

Enquiries:

Carclo plc

01924 268040

Chris Malley, Chief Executive

Weber Shandwick Financial

020 7067 0700

Nick Oborne

Tom Jenkins

Notes to editors

Carclo plc is a public company whose shares are quoted on the Main Market of the London Stock Exchange.

Carclo's strategy is to develop and expand its key manufacturing assets in markets where there remain significant further opportunities to drive shareholder value. To enhance profit margins and support its customers, the group has been investing across its global footprint.

Approximately three fifths of Group revenues are generated from the supply of fine tolerance, injection moulded plastic components, mainly for medical products. The balance of Group revenue is derived mainly from the design and supply of specialised injection moulded LED based lighting systems to the premium automotive industry.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFKQDDOBKDODD
Date   Source Headline
10th Jul 20185:50 pmRNSForm 8.3 - [Carclo plc]
10th Jul 20185:27 pmRNSForm 8.3 - [Carclo plc]
10th Jul 20184:10 pmRNSForm 8.3 - [carclo plc]
10th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
10th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
10th Jul 20189:57 amBUSForm 8.3 - Carclo PLC
9th Jul 20183:55 pmRNSForm 8.3 - Carclo plc
9th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
9th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
9th Jul 201810:39 amRNSForm 8.3 - Carclo plc
6th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
6th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
5th Jul 201812:09 pmRNSForm 8 (OPD) - CONSORT MEDICAL PLC
5th Jul 201812:08 pmRNSForm 8 (OPD) - Carclo plc
5th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
4th Jul 20183:04 pmRNSHolding(s) in Company
4th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
4th Jul 201810:26 amRNSForm 8.3 - Carclo plc
3rd Jul 20184:22 pmRNSForm 8.3 - Carclo Plc
3rd Jul 20182:33 pmPRNForm 8.3 - Carclo plc
3rd Jul 20182:26 pmRNSForm 8.3 - [Carclo plc]
3rd Jul 20181:56 pmRNSForm 8.3 - Carclo Plc
3rd Jul 20181:49 pmRNSHolding(s) in Company
3rd Jul 20181:32 pmRNSForm 8.3 - Carclo plc
3rd Jul 20181:00 pmRNSForm 8.3 - Carclo plc
3rd Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
3rd Jul 201811:36 amBUSForm 8.3 - Carclo plc - Ordinary shares
3rd Jul 201811:07 amRNSForm 8.3 - [Carclo plc]
2nd Jul 20181:07 pmRNSResponse to announcement from Consort Medical
2nd Jul 20187:00 amRNSNon-Binding Proposal for Carclo plc
28th Jun 20187:00 amRNSBoard changes
6th Jun 201810:27 amRNSHolding(s) in Company
5th Jun 20187:00 amRNSFinal Results
17th Apr 20187:00 amRNSDirectorate Change
9th Apr 20188:25 amRNSYear End Trading Update
26th Jan 20185:25 pmRNSDirector/PDMR Shareholding
24th Jan 201812:43 pmRNSDirector/PDMR Shareholding (Replacement)
24th Jan 201810:12 amRNSDirector/PDMR Shareholding
17th Jan 201811:27 amRNSHolding(s) in Company
16th Jan 201811:44 amRNSHolding(s) in Company
15th Jan 20187:00 amRNSTrading Update and Board Changes
12th Jan 20182:55 pmRNSHolding(s) in Company
12th Jan 20181:45 pmRNSHolding(s) in Company
10th Jan 20185:01 pmRNSHolding(s) in Company
28th Nov 20175:30 pmRNSHolding(s) in Company
14th Nov 20177:00 amRNSHalf-year Report
3rd Oct 20179:42 amEQSEdison Investment Research Limited: Edison issues outlook on Carclo (CAR)
26th Sep 20171:34 pmRNSDirectorate Change
21st Sep 20172:40 pmRNSHolding(s) in Company
8th Sep 201711:44 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.